Lawrence P. Wennogle, Vice President, Drug Discovery at Intra-Cellular Therapies, Inc. (ITCI), sold 5,000 shares at $15.00 ($75K) on 2014-05-27, disclosed to the SEC on 2014-05-29.
Open-market sale of $75k ITCI by Vice President, Drug Discovery. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ITCI | SELL | 2014-10-15 | $54K | — | Filing → |
| ITCI | SELL | 2014-10-10 | $71K | — | Filing → |
| ITCI | SELL | 2014-10-07 | $247K | — | Filing → |